Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors
Clinical trial NCT05429762 · TERMINATED
Trial details
- NCT number
- NCT05429762
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2023-08-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.